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Abstract The consecutive cell activation, including Ca2+-
channel opening, and pore formation leading to human neutrophil
lysis were the two functions of the staphylococcal Panton-
Valentine leucocidin attempted to be discoupled by site-directed
mutagenesis. In a first approach consisting in deletions of the
cytoplasmic extremity of the transmembranous domain, we
produced a LukF-PV vSer125-Leu128 with a slightly reduced
Ca2+ induction but with a significantly lowered lytic activity
when combined with its synergistic protein LukS-PV. The second
approach consisted in the modification of charges and/or
introduction of a steric hindrance inside the pore, which also
led to interesting mutated proteins: LukF-PV G131D, G131W
and G130D. The latter had an intact Ca2+ induction ability while
the lytic one was 20-fold diminished. Binding properties and
intrinsic pore diameters of these discoupled toxins remained
comparable to the wild-type protein. The mutated proteins
promoted interleukin-8 secretion, but they were rather inactive in
an experimental model. New insights are brought concerning the
role of the two functions in the virulence of this bi-component
leucotoxin.
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1. Introduction
Staphylococcal bi-component leucotoxins constitute a fam-
ily of pore-forming toxins [17] acting by the sequential inter-
actions with target membranes of two distinct classes of pro-
teins named S (31^32.5 kDa) and F (34^35.5 kDa). Among
these toxins, the Panton-Valentine leucocidin (PVL) was the
¢rst to be described [16,23]. PVL is speci¢c of rabbit and
human polymorphonuclear cells (PMNs), generating in£am-
matory response in vitro which involves chemotactic and vas-
odilatating factors [7,8]. The production of PVL by Staphylo-
coccus aureus strains was associated with necrotising
pyodermites such as furuncles [2]. Injections of PVL in a
rabbit experimental model induced dermonecrosis [3,6].
LukS-PV, one of the two PVL components, binds ¢rst to
membranes, then allowing the binding of the second compo-
nent LukF-PV and consecutive biological e¡ects [1,13]. Early
e¡ects were recently distinguished by using speci¢c inhibitors
as ¢rst as cell activation triggering Ca2 metabolism prior to
the pore formation or lytic activity, sensitising cells to some
monovalent cations [19].
Bi-component leucotoxins belong to the family of pore-
forming toxins rich in L-sheet structures. Binding, oligomer-
isation, pre-pore formation and insertion into the membranes
are generally admitted to be essential steps before the pores
become functional [4,10]. The three-dimensional structures of
the water-soluble form of LukF-PV [15] and HlgB [14], two
related class F components composing PVL and Q-haemoly-
sin, appeared recently. LukF-PV and HlgB are 70% identical
in sequence, and their three-dimensional structures are very
similar, comprising three distinct domains: (1) a L-sandwich
of two six-stranded antiparallel L-sheets which take part in the
cap domain described for the heptameric structure of the K-
toxin [18], (2) a four-stranded open face L-sandwich topped by
several turns and helical segments which is involved in the rim
domain of the K-toxin heptamer, (3) a small domain of three
L-sheets (Fig. 3A). From the comparison with the three-di-
mensional structure of the lipostable heptameric form of the
K-toxin, the extended stem which constitutes the transmem-
brane L-barrel after oligomerisation appeared to be condensed
as the three-stranded L-sheets in the water-soluble monomer.
A hydrophobic interface is involved between this domain and
the L-sandwich core. As the stem domain constitutes the
transmembrane pore once toxins are assembled and inserted
into the membrane (Fig. 3B), it may represent a target for
discoupling cell activation from pore-formation of bi-compo-
nent leucotoxins. Its involvement in these two distinct func-
tions and their respective roles in virulence of the staphylo-
coccal bi-component leucotoxins were investigated.
2. Materials and methods
2.1. Bacterial strains and vectors
Escherichia coli XL1 Blue cells [recA1 endA1 gyrA96 thi1 hsdR17
supE44 relA1 lac (FP proAB lacIq ZvM15 Tn10 (tetr))] were used as
recipient cells after site-directed mutagenesis of recombinant plasmids
(Stratagene, Montigny le Bretonneux, France). E. coli BL21 [F3,
ompT, hsdS (rB3, mB3), gal) was used for the overexpression of
glutathione S-transferase (GST)-fused leucotoxins, after being electro-
porated as recommended (Pharmacia, Uppsala, Sweden). pGEX 6P-1
(Pharmacia) was the expression vector for leucotoxins and their mu-
tants.
2.2. Cloning and expression of LukF-PV in E. coli
Proteins were expressed in E. coli through the gene fusion system
(GST, Pharmacia). Brie£y, DNA sequences corresponding to secreted
proteins and containing the putative 3P inverted repeats were ampli¢ed
via dedicated oligonucleotides containing EcoRI restriction sites at
their 5P-end. After EcoRI restriction, ampli¢ed DNA fragments
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were cloned into pGEX-6P-1. The right oriented recombinant plas-
mids were used as templates for site-directed mutagenesis, achieved by
using the Quick Change Mutagenesis kit (Stratagene). Brie£y, reac-
tions were performed in the presence of 5 ng of template (5.8 kb), 0.25
mM dNTP, 0.4 nM of each oligonucleotide and 5 U of Pfu Turbo
DNA polymerase in 50 Wl. Temperatures of hybridisation, elongation
and denaturation were 50‡C, 68‡C and 95‡C during 30 s, 3 min 30 s
and 1 min, respectively. Initial templates were eliminated with a 80
min DpnI restriction and 2.5 Wl aliquots were used to transform 80 Wl
of XL1 Blue Supercompetent cells as recommended (Stratagene). Mu-
tated genes were sequenced [20] before to be electroporated at 1.8 kV,
200 6, 25 WF in 80 Wl of E. coli BL 21 previously stored at 5.0
OD600 nm units in 0.1 mM HEPES, pH 7.0. Transformed bacteria
were treated and plated as recommended (GST, Pharmacia).
2.3. Puri¢cation of E. coli recombinant leucotoxin components
Recombinant E. coli BL 21 mutated clones were inoculated from a
starter into 2U400 ml of 2UTY ¢lled in 2 l Erlenmeyer £asks, and
cultivated for 6 h before overnight induction of the GST fused protein
with 0.2 mM IPTG. Bacteria were harvested by centrifugation and
concentrated as a 30% (w/v) suspension into 30 mM Na-phosphate,
150 mM NaCl, 1 mM EDTA, pH 7.0. Then, bacteria were sheared at
9000 Pa/si with a French Pressure Cell Press (SLM Instruments-Bio-
ritech, Joinville sur Juine, France). Cell debris were discarded by a 30
min centrifugation at 30 000Ug at 6‡C and GST activity of the lysate
was measured at 340 nm as recommended. A volume of lysate corre-
sponding to 4 mg of titrated GST was applied on a glutathione Se-
pharose 4B column (Pharmacia) equilibrated with 60 mM Tris-HCl,
pH 8.0. The fused protein was eluted in the same bu¡er containing 30
mM glutathione, and further digested overnight by 5 U/mg of PreS-
cission protease (Pharmacia). The leucotoxin components were puri-
¢ed through a 1.35 M to 0.45 M (NH4)2SO4 gradient applied on an
AlkylSuperose fast performance liquid chromatography (FPLC, Phar-
macia), which eluted at 0.75 M (NH4)2SO4. The pre-puri¢ed F com-
ponents were dialysed against 30 mM MES, pH 6.3 and puri¢ed to
homogeneity by a MonoS FPLC through a 0 to 150 mM NaCl gra-
dient, with elution around 90 mM NaCl. Puri¢ed proteins were con-
trolled by SDS-PAGE and radial gel immunoprecipitation and stored
at OD280 nm = 1.0 at 380‡C. None of the proteins discussed below
presented apparent variations in their physicochemical properties.
2.4. Labelled proteins
LukF-PV Ser27Cys, a functional cysteine mutated protein was la-
belled with £uorescein 5-maleimide (Molecular Probes, Leiden, The
Netherlands) at a 5-fold excess for 30 min at room temperature as a
10 WM protein solution in 50 mM Na-phosphate, 0.15 M NaCl, 1 mM
EDTA Na2, pH 7.0. The coupling reaction was stopped by the addi-
tion of 10 mM L-mercaptoethanol. The mixture was then desalted and
the coupling yield was determined by the ratio of the determined
concentration of £uorescein (O490 nm = 81 900 cm31 mol31) and that
of the protein determined by the Bradford titration (Bio-Rad, Ivry
sur Seine, France).
LukF-PV Gly130Cys and LukF-PV Gly131Cys, at 40 WM in 0.2 M
Na-phosphate, 1 mM L-mercaptoethanol pH 8.0 were labelled with 15
mM AMSD [4 acetamido-4P maleimidyl stilbene 2,2P disulfonic acid,
disodium salt dissolved at 0.1 M in H2O, O320 nm = 29 000 M31. cm31
(Molecular Probes)] in dark at room temperature for 30 min. Reac-
tion was stopped by adding 30 mM L-mercaptoethanol for 30 min in
the dark. Protein solutions (Gly130Cys* and Gly131Cys* in the text)
were then centrifuged for 10 min at 8000Ug at 4‡C, and peptides
puri¢ed onto a FPLC MonoS chromatography using a NaCl gradient
ranging from 0 to 700 mM NaCl in 50 mM NaH2PO4 pH 7.0, stored
in dark at 4‡C at OD280 nm = 1.0.
2.5. Human polymorphonuclear cells (PMNs) and £ow cytometry
measurements
Thirty mililitres of bu¡y coats from healthy donors diluted with 10
ml of 0.9% (w/v) NaCl were added to 12 ml of J-Prep solution (Tech-
Gen) and human PMNs were puri¢ed as previously reported [6]. Cells
were suspended and adjusted to 2U106 cells/ml in 140 mM NaCl,
5 mM KCl, 10 mM glucose, 0.1 mM ethylene glycol-bis(beta-amino-
ethyl ether)N,N,NP,NP-tetraacetic acid, 10 mM HEPES, 3 mM Tris-
base (pH 7.3). Flow cytometry experiments were made with 5U105
cells/ml loaded in 5 WM Fluo-4 solution (Molecular Probes, Eugene,
OR, USA) during 1 h at 37‡C in the latter bu¡er, then washed and
resuspended in the presence of 1.1 mM Ca2 for the evaluation of
Ca2 entry. Each component constituting the leucotoxins tested was
generally added at 1 nM. Flow cytometry measurements from 3000
gated leucocytes were performed as previously described [12,13] by
using a FacSort cytometer (Becton-Dickinson, Le Pont de Claix,
France). Fluo-4 £uorescence due to the calcium penetration was re-
corded from the £uorescence light 1 (FL1: Vem = 530 nm), every 30 s
during 45 min. After subtraction of basic £uorescence, the results were
compared to the maximum £uorescence of controls indicating the
potentiality of the di¡erent puri¢ed leucotoxins to open Ca2 chan-
nels. The £uorescence light 3 (FL3: Vem = 650 nm) was used to record
ethidium £uorescence, applied at 25 nM together with the leucotoxins.
This £uorescence increased after the molecule entered the cell mem-
brane by the pores formed because of combination with nucleic acids.
Means of four series of data, at least, obtained from PMNs of four
di¡erent donors were calculated by Lysis 2TM software (Becton-Dick-
inson, France). Results were expressed as mean £uorescence percen-
tages from controls. Standard deviations were mentioned in Table 1.
By using a full functional £uorescein-labelled LukF-PV Ser27Cys,
binding abilities of LukF-PV and inactive mutants combined with
3 nM LukS-PV were determined by competition experiments in the
absence of extracellular calcium using a concentration of 20 nM of the
labelled LukF-PV Ser27Cys, and variable concentrations of 1, 5, 10,
20, 50, 100 and 200 nM of the mutated proteins. The residual
£uorescences at the cell surface were gated during 50 min after the
application of the protein couples LukS-PV+X to minimise the in£u-
ence of lysed cells in the data. Apparent inhibition constants (Ki app)
were deduced by projection to abscissa of the 50% mean £uorescence
values (IC50), with the following equation:
K i app  IC50=1 F=Kd F
where [F] is the concentration of the £uorescent LukF-PV Ser27Cys
and KdF = 3 nM (D.A. Colin, personal communication).
Pore diameters created by leucotoxins were assessed by an evalua-
tion of the FSC of treated cells (5U105 cells/ml) with 1 nM of LukS-
PV and 20 nM of F component and 30 mM of polyethylene glycol
(PEG) beads of di¡erent radius (0.94, 1.2, 1.22 and 1.44 nm). Forward
light scatter values were collected at 0, 10, 20 and 30 min after toxin
application.
2.6. IL-8 titration
Equimolar amounts (1 nM) of PVL or LukS-PV/LukF-PV G130D,
or LukS-PV/LukF-PV vSer125-Leu128 were applied for 20 min at
room temperature to 0.5 ml of the bu¡er cited in Section 2.5, 1.1
mM CaCl2 containing 5U105 cells/ml. After treatment, washed cells
corresponding to half the volume of the assays was treated for lysis
with 0.2% (v/v) Triton X-100 (Boehringer). Cells or cell debris were
immediately pelleted at 4‡C and 50 Wl of the supernatant were sub-
jected to IL-8 titration. IL-8 from secretion £uids or cell lysates was
titrated with an ELISA kit used as recommended by the manufacturer
(Endogen-Interchim, Montluc°on, France).
2.7. Activity of modi¢ed LukF-PV in rabbit skin
Shaved rabbits of at least 2.5 kg were injected intradermally with 50
Wl of sterile 9.55x (w/v) PBS Dulbeccos solution with equal amounts
(300, 1000, 3000 or 10 000 ng) of LukS-PV and native or mutated
LukF-PV. Macroscopic clinical observations were recorded at 24
and 48 h after injection of toxins. Five reaction levels [6] correspond-
ing to the intensity of the in£ammatory reaction were attributed: level
0 was the normal skin, level 1 showed a red in£ammatory reaction
(diameter = 10^15 mm) without abscess formation, level 2 showed a
hot, red papule with relief (diameter = 15^20 mm, 5 mm high), level 3
showed a more intense abscess (diameter = 20^30 mm, 10 mm high)
becoming blue and oedematous, level 4 still progressed in intensity
(diameterv30 mm, 10^15 mm high) with white pus collection sur-
rounded by blue oedema, level 5 showed a lesion in progress with a
central depression and pus sweating.
3. Results
3.1. Ca2+ and ethidium entries induced by the mutated proteins
Substitutions of LukF-PV by di¡erent residues were gener-
ated at two glycine positions: Gly130Asp, Gly130Cys,
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Gly130Lys, Gly130Trp, Gly131Asp, Gly131Cys and
Gly131Trp. The two cysteine mutants were further labelled
with AMSD, a 18 Aî long compound with a rigid structure
except at the label extremity. Deletions in the stem domain
were also engineered (Luk-PV vIle124-Ser129, vSer125-
Leu128, vLeu128-Ser135) in order to reduce the length of
the transmembrane moiety of the toxin. Such a con¢guration
might favour the partial obturation of the cytoplasmic edge of
the pore by membrane phospholipids.
Table 1 and Fig. 1 show the biological activities on human
PMNs of all modi¢ed PVL made of the native LukS-PV and
of the mutated proteins. Table 1 gives lag times (Lag-T) for
both Ca2 and ethidium entries as well as the ratio of the
maximal £uorescence of the modi¢ed leucotoxins compared
to the native PVL. Fig. 1 gives representative curves of
Ca2 and ethidium entries representative for several mutated
leucotoxins. Four groups of mutated proteins were di¡erenti-
ated according to their biological activities:
1. LukF-PV Gly130Cys, Gly130Lys, Gly130Trp, and
Gly131Cys were as active as the native toxin for both the
Ca2 and ethidium entries (Table 1 and Fig. 1C,F).
2. On the contrary, two deletion mutants LukF-PV vLeu128-
Ser135 and vIle124-Ser129 displayed no activity (Table 1
and Fig. 1A,D).
3. Two other modi¢ed proteins, LukF-PV Gly130Cys* and
Gly131Cys*, presented concerted decreases in the two bio-
logical activities. These decreases were signi¢cant since the
kinetic e¡ects when using 1 nM of these mutated proteins
were similar to those obtained with only 0.05 nM of native
PVL (Fig. 1C,F). The lag times for the entries of Ca2 and
ethidium (Table 1) amounted 5 and 30 min compared to
1.5 and 5 min for native PVL (1 nM), respectively. The
maximal £uorescence intensity for the Ca2 induction and
for ethidium entry represented 30^40% and 85% of that
induced using 1 nM of PVL, respectively. When the con-
centration of the mutated leucotoxins was increased to 10
nM, both activities were larger, but did not reach those
measured with 1 nM PVL (Fig. 1C,F). Therefore, these
two mutated and chemically modi¢ed proteins were at least
10-fold less active than PVL.
4. When combined with LukS-PV, four mutated proteins
LukF-PV vSer125-Leu128, LukF-PV Gly131Asp,
Gly131Trp and Gly130Asp showed di¡erences in Ca2 in-
duction and pore-formation. LukF-PV vSer125-Leu128
was inducing Ca2 entry at a level comprised between
those observed with 1 nM and 0.1 nM of PVL (Fig. 1A).
Lag times for Ca2 and ethidium were 6 2.5 and 30 min,
respectively, whereas maximal £uorescences reached 89%
of that of PVL (Table 1 and Fig. 1A,D). Ca2 entry using
10 nM of this modi¢ed leucotoxin was larger than with
1 nM PVL, whereas ethidium entry remained similar to
that observed using 0.1 nM LukF-PV (Fig. 1D). It was
assumed that, for LukS-PV+LukF-PV vSer125-Leu128,
ethidium penetration was about 10-fold more inhibited
than Ca2 induction. Similar results were obtained for
LukF-PV Gly131Asp, and Gly131Trp (Table 1 and Fig.
1B,E), except that the corresponding leucotoxins fully in-
duced Ca2 entry, while ethidium entry was delayed with a
lag time of 20 min and corresponded to a 10-fold decrease
of activity. These discrepancies were larger with LukF-PV
Gly130Asp. The latter induced Ca2 entry in human
PMNs in the same way as LukF-PV but ethidium penetra-
tion was considerably decreased. The lag time was around
30 min and a maximum of 70% of £uorescence intensity
was only reached after 120 min, while this value was ob-
tained after only 60 min with PVL. This mutated protein
was assumed to be at least 20-fold less functional with
respect to pore formation than PVL, although Ca2 induc-
tion appeared fully conserved. Morphologic (side light
scatter) and granularity (forward light scatter) parameters
recorded during £ow cytometry for these mutants ac-
counted for a diminished lytic property of this mutated
toxin compared to PVL.
Table 1
Compiled values for each mutated LukF-PV protein combined with LukS-PV
Ca2 entry Ethidium entry Ki app
(nM)
Pore radius
(nm)
IL-8 Dermo. dose
(ng toxin)
Lag-Ta
F U100
F  LukF3PV
b
Lag-Ta
F U100
F  LukF3PV
b
Sec.b Cell.b
LukF-PV 6 1.5 100 5 100 3.2 1.2 102 þ 8 316 þ 22 2 000
G130D 6 1.5 88 þ 7.4 30 70 þ 8.2 3.9 1.2 106 þ 8 340 þ 16 s 20 000
G130W 6 2.5 95 þ 2 10 97 þ 1.6 nd nd 98 þ 6 286 þ 16 2 000
G130K 6 2.5 98 þ 1.9 10 91 þ 1.9 nd nd nd nd nd
G130C 6 2.5 95 þ 0.8 5 97 þ 1.8 nd nd 102 þ 6 288 þ 18 2 000
G131C 6 2.5 94 þ 0.6 10 96 þ 0.6 nd nd nd nd nd
G131D 6 2.5 94 þ 2 20 91 þ 2.7 2.8 1.2 nd nd 6 000
G131W 6 2.5 88 þ 2.1 20 91 þ 2.2 3.4 nd 84 þ 8 290 þ 18 6 000
vS125-L128 6 2.5 89 þ 6.7 30 89 þ 9.1 1.17 1.2 110 þ 6 286 þ 14 20 000
vL128-S135 ^ 9 ^ 6 þ 2 s 70 ^ nd nd nd
vI124-S129 ^ 9 ^ 7 þ 2 6.2 ^ nd nd s 20 000
G130C* 5 38 þ 9.3 30 84 þ 0.9 14.3 1.2 45 þ 6 408 þ 8 20 000
G131C* 5 48 þ 8.4 35 84 þ 8.6 13 nd nd nd nd
Lag times (Lag-T), £uorescence maxima (F*) expressed as percentages from controls for calcium (revealed by Fluo-4 £uorescence) and ethidium
entries; apparent Ki, binding constants in competition with Luk-PV S27C-£uorescein; pore radius; ng of secreted (Sec.) and cellular (Cell.)
IL-8 induced by a 20 min treatment of 2U105 human PMNs/200 Wl with 1 nM of leucotoxins; and minimal doses necessary to obtain an acute
dermonecrosis (Dermo. dose) in the rabbit skin.
aRepresentative values of four di¡erent experiments.
bMean þ S.D. of four di¡erent experiments.
FEBS 22887 11-11-99 Cyaan Magenta Geel Zwart
L. Baba Moussa et al./FEBS Letters 461 (1999) 280^286282
Fig. 1. Evaluation by £ow cytometry of the Ca2 penetration (A, B and C) and of the pore-forming abilities (D, E and F) according to time,
of LukS-PV+LukF-PV or modi¢ed proteins (indicated horizontally), on human PMNs. Curves were calculated as means of four di¡erent ex-
periments on di¡erent donors and expressed as percentages of maximum of £uorescence. Standard deviations are mentioned in Table 1. Ca2
entry (left) was recorded in the presence of 1.1 mM extracellular CaCl2 from Fluo-4-charged cells. Pore-formation indicated by ethidium £uo-
rescence after its combination with nucleic acids was achieved in the absence of extracellular calcium. The decrease of Fluo-4 £uorescence was
assumed as a natural loss of the probe and/or a loss due to cell lysis.
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3.2. Binding of the mutated LukF-PV proteins
To determine the binding properties of mutated LukF-PV
on the LukS-PV-membrane complexes, competition experi-
ments with the fully functional £uorescein-labeled LukF-PV
Ser27Cys were performed. As shown in Table 1 and Fig. 2A,
the most interesting proteins (e.g. Gly130Asp, Gly131Asp,
Gly131Trp and vSer125-Leu128) displayed Ki app between
1.2 and 3.9 nM. Despite the lack of biological activity,
LukF-PV vIle124-Ser129 signi¢cantly binds to the LukS-PV-
membrane complexes with Ki app = 6.2 nM. LukF-PV
Gly131Cys* and Gly130Cys* binds less e⁄ciently with
Ki app = 13^14 nM. The LukF-PV vLeu128-Ser135 seemed de-
void of binding to those complexes.
3.3. Pore diameters created by modi¢ed leucotoxins
The intrinsic diameter of pores formed by native and modi-
¢ed leucotoxins was assessed using £ow cytometry by a quan-
titative evaluation of the modi¢cation of the cell granularity
which follows the application of calibrated polyethylene glycol
beads. Some of the protein couples tested, PVL, LukS-
PV+LukF-PV vSer125-Leu128 (Fig. 2B) or for LukS-
PV+LukF-PV Gly130Cys* or Gly131Asp (Fig. 2C), or
LukS-PV+LukF-PV Gly131Trp or Gly131Cys* (data not
shown) formed pores and excluded PEG beads of a radius
greater than 1.2 nm. However, it appeared that cell disorders
(forward light scatter) induced by the couple LukS-PV+LukF-
PV Gly130Asp (Fig. 2C) did not occur as fast as with PVL.
Finally, permeability was not signi¢cant for modi¢ed leuco-
toxins composed with LukF-PV vLeu128-Ser135 or vIle124-
Ser129 (Fig. 2B), even 30 min after protein application.
3.4. IL-8 secretion induced by modi¢ed leucotoxins
Secretion of IL-8 from human PMNs treated by leucotoxins
was evidenced by titration of the cytokine (Table 1). PVL
1 nM induced a signi¢cant secretion of IL-8 (102 þ 8 ng/ml)
but the total cell content of IL-8 remained larger (316 þ 22 ng/
ml). Similar results were obtained using a series of modi¢ed
leucotoxins such as LukF-PV Gly130Asp, Gly130Trp,
Gly130Cys, Gly131Trp, vSer125-Leu128. LukF-PV
Gly130Cys* which displayed a decreased Ca2 induction
and ethidium entry did not promote secretion of IL-8
(45 þ 6 ng/ml). The sum of secreted (15 þ 2 ng/ml) and total
IL-8 content for non-treated cells (472 þ 21 ng/ml) equals that
of PVL-treated cells. Increase of toxin concentration to 5 nM
did not in£uence amounts of total IL-8. Treatment of human
PMNs by PVL for 80 min led to the secretion of IL-8 at
422 þ 31 ng/ml and to a cell content of 186 þ 12 ng/ml, where-
as LukS-PV+LukF-PV Gly130Asp led to only 136 þ 13 ng/ml
of secreted IL-8 and to a cell content of 396 þ 23 ng/ml.
3.5. In£ammatory reaction promoted by modi¢ed leucotoxins
To determine whether host in£ammatory reaction can be
attributed to the activation function of leucotoxins, PVL and
some modi¢ed leucotoxins were compared for their ability to
induce dermonecrosis in rabbit skin (Table 1). When injected
in the rabbit skin, dermonecrosis with pus collection (level
4) was clearly induced with 2000 ng of PVL (1000 ng of
each component), or LukS-PV+LukF-PV Gly130Trp, or
+Gly130Cys within 48 h, whereas similar levels of dermonec-
rosis were obtained with 6000 ng of LukS-PV+LukF-PV
G131D, or +G131W. Comparable lesions were obtained
with 20 000 ng of LukS-PV+LukF-PV vSer125-Leu128, or
+Gly130Asp.
Doses of 20000 ng of LukS-PV+LukF-PV vIle124-Ser129,
or +Gly130Cys* only induced a dermanecrotic reaction at
level 2. Therefore, it appeared that leucotoxins with decreased
pore-formation ability were at least 10-fold less virulent than
PVL on the rabbit skin.
4. Discussion
In this study, we provided evidence that mutant proteins of
LukF-PV enabled the discoupling of the Ca2 induction and
of the pore-formation activities of a staphylococcal bi-compo-
Fig. 2. A: Binding competition experiments to LukS-PV-PMNs membranes complexes between the £uorescein-labelled LukF-PV Ser27Cys and
LukF-PV (F), LukF-PV Ser27Cys (FS27C), LukF-PV Gly130Asp (FG130D), LukF-PV vSer125-Leu128 (F vSer125-Leu128), LukF-PV
vLeu128-Ser135 (F vLeu128-Ser135), according to percentages of £uorescence intensities and concentration of F components. B and C: Prob-
ing the diameter of pores with calibrated PEG molecules, formed by modi¢ed leucotoxins: LukS-PV combined with LukF-PV (F), LukF-PV
Gly130Cys* (FG130C*), LukF-PV Gly130Asp (FG130D), LukF-PV Gly131Asp (FG131D), LukF-PV vSer125-Leu128 (F vSer125-Leu128),
LukF-PV vIle124-Ser129 (F vIle124-Ser129), LukF-PV vLeu128-Ser135 (F vLeu128-Ser135). Forward light scatter variations (FSC) were re-
corded at 10, 20 and 30 min following toxin application.
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nent leucotoxin. Pore-formation was reduced or cancelled by
mutagenesis in the stem domain [15]. Residues Gly-130 and
Gly-131 in LukF-PV (Fig. 3A), which were replaced by di¡er-
ent amino acids, correspond to Ile-132 and Gly-133 of the K-
toxin, located in the outer and the inner lea£et of the hepta-
meric pore [18,21,22], respectively. According to the hexamer
model of PVL [15], and to the alignment with the K-toxin
sequence [4,5], Gly-130 and Gly-131 would have homologous
locations. Three deletion mutants were engineered. Two of
them, LukF-PV vSer125-Leu128 and vIle124-Ser129 map in
the ST2 L-sheet [15] and in the following loop of the mono-
meric protein, respectively. These deletions also map at the
bottom of the stem in the pore-forming oligomer, vLeu128-
Ser135 removed half of the cross-over loop between strands
ST2 and ST3 in the monomer, and part of a L-sheet in the
pore-forming stem ([15], see Fig. 3A,B). This deletion led to a
protein which did not bind signi¢cantly to the membrane-
LukS-PV complex. Residues 128^135 are solvent-exposed in
the monomeric structure [15] and should contribute to proper
fold of the stem domain and to binding e⁄ciency of the hy-
drosoluble LukF-PV.
When combined with LukS-PV, LukF-PV vIle124-Ser129
and Gly130Cys* and Gly131Cys* showed a drastic decrease
in biological activities. LukF-PV vIle124-Ser129 which binds
to the membrane-LukS-PV complex but does not activate cells
and generate pore-formation, might prevent insertion of the
pre-pore or promote incorrect structuration of the L-barrel.
Labelling with AMSD resulted in disorganisation of every
step of the pore-construction independently of the inner or
outer location of the substituted residue. AMSD which is a
highly solvated molecule might reorient inside the lumen of
the pores inducing local and charged hindrance.
Finally, one deletion, LukF-PV vSer125-Leu128, and three
substitutions, Gly130Asp, Gly131Asp and Gly131Trp led to modi¢ed
leucotoxins for which pore-formation and Ca2 entry were discoupled in
various extents. The major e¡ect was observed with LukS-PV+LukF-
PV Gly130Asp. Polar incompatibility between the latter mutant and the
membrane seemed to disturb only local topology since IL-8 secretion
and permeability to PEG were conserved. Substitutions of LukF-PV
Gly-131 by Asp or Trp led to similar results. The carboxylate or the
indole ring might interact with either the quaternary amine or the
hydrophobic part of ethidium, respectively. The vSer125-Leu128
produced a modi¢ed LukF-PV able to bind the LukS-PV-membrane
complex and to create pores with a low sensitivity to ethidium.
According to the model of hexameric PVL ([15], Fig. 3B), such a
Fig. 3. Ribbon representation of the stem domain (A) in the water-soluble monomeric LukF-PV and (B) in a molecular transmembrane pore
of PVL [15]. The LukF-PV and LukS-PV components are shown in green and blue, respectively. Positions of the residues that were either sub-
stituted or which line deleted regions are shown as red and yellow dots, respectively. The ¢gure was produced by using the programs Molscript
[9], and Raster 3-D [11].
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deletion shortens the edge of the stem domain, and likely disturbs the
intracellular part of the L-barrel, though allowing the tra⁄c of solvated
PEG molecules.
The leucotoxins formed by LukS-PV+LukF-PV
Gly130Asp, +Gly130Cys, +Gly130Trp, +Gly131Trp, or
+vSer125-Leu128 that lacked pore-formation induced a sim-
ilar secretion of IL-8 as PVL, supporting that leucotoxins
have cell-activation properties [8]. The less Ca2 inducer,
LukS-PV+LukF-PV Gly130Cys*, was observed to induce a
less e⁄cient IL-8 secretion.
Furthermore, when challenged in a rabbit dermonecrosis
experimental model [3,6], LukF-PV Gly130Asp and
vSer125-Leu128 were less in£ammatory when combined
with LukS-PV. It suggests that pore-formation is an essential
function for the virulence of PVL. In view of the delay be-
cause of delay between the two activating and the lytic func-
tions, one may hypothesise the ¢rst cited function favours
potential of cells, while cell lysis is required to amplify in£am-
mation. Such a process may also be essential to provide nu-
trients for the bacterial growth and spreading, whereas cell
debris generated by the lytic activity may complicate the gen-
eral immune response. This study showed that it may be pos-
sible to discouple the cell-activating and the lytic properties of
PVL, and may be some pore-forming toxins. The structural
basis of these two functions should be assessed to de¢ne their
respective roles in virulence.
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